Upstart Takes Step to Address Funding Risk, but Balance-Sheet Exposure Remains Key Concern

What happened

Upstart has taken a major step to reduce its dependence on third-party funding by applying for a national bank charter, which could eventually provide a cheaper and more stable source of capital. However, the company still holds $985M in loans on its balance sheet and recently required a warehouse covenant waiver in January 2026, revealing ongoing funding fragility. While the charter application is a positive development, it will take months to potentially years to gain approval and ramp operations, offering no near-term relief. In the interim, Upstart's biggest risk remains its ability to keep moving loans off balance sheet and maintain third-party funding at attractive terms, given high partner concentration. The stock's elevated valuation at ~57x EBITDA leaves little room for any funding disruption or covenant breach, keeping the risk/reward unfavorable.

Implication

The bank charter, if approved, could structurally lower funding costs and reduce reliance on fickle institutional investors, but regulatory approval is uncertain and may come with conditions that limit its benefits. In the meantime, the balance-sheet loan pile (nearly $1B) and concentration in top partners (83% of originations from top three) remain vulnerabilities that could force deleveraging. The stock's high enterprise value-to-EBITDA multiple (57x) prices in optimistic scenarios that may not materialize quickly, especially if credit conditions worsen. A safer entry point may emerge if the stock pulls back below $30, offering a better risk/reward for patient investors willing to wait for execution proof. Until then, the thesis remains wait-and-see, with any further covenant waiver or balance-sheet expansion triggering a downgrade.

Thesis delta

The bank charter application represents a tangible step toward reducing the biggest risk—funding dependence on third parties—but does not alter the near-term thesis. We still need observable proof that balance-sheet loans shrink and no repeat covenant waivers occur before turning more constructive. This news slightly improves the odds of a bull case but does not change the need for execution evidence.